PANTHERx® Rare Pharmacy Selected by Ultragenyx Pharmaceutical to Distribute DOJOLVI™ (triheptanoin), for Patients with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)
Read the Official PANTHERx Press Release.
PANTHERx® Rare Pharmacy announces that it has been selected by Ultragenyx Pharmaceutical...
Read More
PANTHERx® Chosen as Exclusive Rare Pharmacy Partner by Viela Bio, Inc. for Uplizna™ (inebilizumab-cdon) for Adult Patients with AQP4+ Neuromyelitis Optica Spectrum Disorder (NMOSD)
Read the Official PANTHERx Press Release.
PANTHERx® Rare Pharmacy announces that it has been selected by Viela Bio, Inc....
Read More
PANTHERx Rare Pharmacy Recognized as a US Best Managed Company
Read the Official PANTHERx Press Release.
PANTHERx Rare Pharmacy (PANTHERx), was officially recognized as a prestigious US...
Read More
PANTHERx® Rare Pharmacy Selected by Deciphera Pharmaceuticals to Distribute QINLOCK™ (ripretinib), for Gastrointestinal Stromal Tumor (GIST) Patients
Read the Official PANTHERx Press Release.
PANTHERx® Rare Pharmacy announces that it has been selected by Deciphera Pharmaceuticals...
Read More
PANTHERx Rare Pharmacy Wins Patient Choice Award for a Record Third Time
Read the Official PANTHERx Press Release.
PANTHERx Rare Pharmacy (PANTHERx) has again been recognized as the winner of the...
Read More
White Paper “Rare Pharmacy Emerges from Specialty (Pharmacy)” Published
Read the Official PANTHERx Press Release.
In a landmark, non-commercial publication available for download, PANTHERx Rare...
Read More
